Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    0.00 (0.00%)
Bid:
82.00
Ask:
0.00
Spread: 22.20 (27.073%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Appointment

20 Feb 2006 14:00

Yule Catto & Co PLC20 February 2006 Yule Catto & Co plc Appointment of Chief Executive Designate Yule Catto is an international producer of speciality chemicals, which aresupplied to global customers, ranging from manufacturers of medical gloves,paint and adhesives to the pharmaceuticals and cosmetics industries Alex Walker, Chief Executive for the past 20 years, will reach normal retirementage for Yule Catto senior executives in August 2006. The Board of Yule Catto &Co plc ("Yule Catto") is therefore pleased to announce that Adrian Whitfieldwill join the Board on 1st March 2006 as Chief Executive Designate. Mr Whitfield, aged 44, has a considerable industrial and internationalbackground, latterly as Chief Executive of the plastics division of D.S. Smithplc and prior to that as Vice President, European Operations, of CrownSimplimatic. His early industrial experience was gained with ICI Chemicals and Polymers,later applied and broadened as a consultant to manufacturing companiesthroughout Europe. He holds a BSc Hons. in mechanical engineering from ImperialCollege, London and is a member of The Institute of Mechanical Engineers. Anthony Richmond-Watson, Yule Catto Chairman, comments: "I am delighted to welcome Adrian to the Board. Together with the rest of theBoard, I am confident that his extensive experience will enable him to build onthe solid foundations laid by Alex Walker and our senior management team." 20 February 2006 YULE CATTO Tel: 01279 442791Anthony Richmond-Watson, ChairmanAlex Walker, Chief Executive COLLEGE HILL Tel: 020 7457 2020Gareth David The company has been notified by Mr Whitfield that there is no information whichis required to be disclosed pursuant to Listing Rule 9.6.13. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.